Pixability launches Partner Connect Program to enhance ad campaignsZiadPixability, a video advertising software company, has launched the Partner Connect Program, which will provide Pixability’s brand and agency customers with a marketplace of video platforms, as well as creative, data, and measurement solutions. Read more >>
Pixability Announces Key Leadership Team HiresZiadPixability, the leading provider of insights and optimizations for video advertising across YouTube, Facebook, and Connected TV, announced a pair of strategic new hires to strengthen its executive team. Matt Duffy will be the new Chief Marketing Officer and Lata Ahuja has been hired as the VP of Engineering. Both will help Pixability maintain its strong momentum during this period of rapid growth for the company. Read more >>
Corbus Pharma (CRBP) Announces Issuance of Composition of Matter Patent Related to LenabasumZiadCorbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company with the industry’s leading pipeline focused on treating inflammatory and fibrotic diseases by targeting the endocannabinoid system, announced today that the U.S. Patent and Trademark Office (“USPTO”) issued Patent No. 10,154,986 to the Company which claims pharmaceutical compositions of lenabasum through 2034. Read more >>
How Businesses Are Helping Their Employees Ditch Student Loan DebtZiadFutureFuel.io, a SaaS platform connecting employers, employees, and student loan servicers, is pushing to “crush” student debt. Read more >>
Bloomsburg University Students Using 3D Tech to Pay It ForwardZiadThree years ago, Jesse Johnson, from Northumberland, was given the gift of sight when he received a pair of eSight glasses. Jesse is a junior at Bloomsburg University and has been legally blind since birth. These electronic glasses allow him to see clearly. Read more >>
Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory DiseasesZiad Pyramid Biosciences, Inc. (www.pyramidbio.com), a Boston-based biotechnology company developing new therapies focused on the modulation of cell surface receptors today announced it has entered into an exclusive, worldwide licensing agreement with AstraZeneca PLC for the development and commercialization rights to a novel Tropomyosin receptor kinase (TRK) modulator, PBI-100. Read more >>
Venture Fast Track: Fundraising Bootcamp for Early Stage Entrepreneurs & Meet 35+ Boston Investors!ZiadThe Capital Network’s Fast Track Boot Camp for Early Stage Entrepreneurs, is an intensive, interactive full-day seminar designed to provide entrepreneurs and innovators an in-depth understanding of what it takes to raise early stage capital. Mentors and Faculty are drawn from New England’s Investment and Entrepreneurship Community and will include members of: Launchpad Venture Group, RevUp Capital, Boston Harbor Angels, Golden Seeds, Cherrystone Angels, PipelineAngels, Mass Med Angels, LearnLaunch Ventures, Sigma Prime Ventures, MassChallenge, Hub Angels, Nutter, Bessemer Venture Partners, Walnut Angels,...
Born blind, this Columbia student sees a brighter future thanks to visionary glasses Read more here: https://www.thestate.com/news/local/article222567185.html#storylink=cpyZiadThe first time Tori Diamond saw the features of her mother’s face, she saw tears. Read more >>